Individualized Duration of Peg-interferon/Ribavirin Treatment of Hepatitis C
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate if the duration of treatment of hepatitis C with
pegylated interferon and ribavirin can be individualized on the basis of how fast the
hepatitis C virus concentration in the blood decreases, and if this is more cost-efficient
than standard treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Göteborg University
Collaborators:
Karolinska University Hospital Lund University Hospital Sahlgrenska University Hospital, Sweden Skane University Hospital Skaraborg Hospital Sodra Alvsborgs Hospital Uddevalla Hospital